Results

Total Results: 149 records

Showing results for "hepatitis".
Users also searched for: hep c

21. Section 1, Tables 1 to 3 (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-1-tables-1-3.pdf
    April 25, 2018 - Section 1, Tables 1 to 3 Table 1: Definition of Severe Sepsis and Septic Shock Term Definition Severe sepsis Sepsis plus one of the following: cardiovascular organ dysfunction OR acute respiratory distress syndrome OR two or more other organ dysfunctions. Sepsis Systemic Inflammatory Response Syndrome (SIRS) …

22. Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/policymakers/chipra/overview/background/appendix-a1.html
    December 01, 2009 - Health information technology HEDIS Healthcare Effectiveness Data and Information Set Hep B Hepatitis

23. Sepsis in the ED Detailed Measure, Technical Specifications (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-detailed_measure-specs.pdf
    August 01, 2014 - Sepsis in the ED Detailed Measure, Technical Specifications Q-METRIC Sepsis Measure 1, ED Protocol for Children with Sepsis Syndrome U18HS020516 Page 41 Submitted August 2014 Sepsis Measure 1: Protocol for Identifying and Treating Children with Sepsis Syndrome in the Emergency Department Desc…

24. Section 2, Technical Specifications (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
    February 09, 2018 - Section 2, Technical Specifications Sepsis Measure 3: Timely Blood Culture for Children with Sepsis Syndrome Description The proportion of hospitalized children with sepsis syndrome who had blood culture drawn within 4 hours of meeting diagnostic criteria for sepsis syndrome. A higher proportion indic…

25. Section 1, Tables 1-4 (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
    June 15, 2018 - Section 1, Tables 1-4 1 Table 1: Definition of Severe Sepsis and Septic Shock Term Definition Severe sepsis Sepsis plus one of the following: cardiovascular organ dysfunction OR acute respiratory distress syndrome OR two or more other organ dysfunctions. Sepsis Systemic Inflammatory Response Syndrome (SIRS) …

26. Search Evidence-Based Reports | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
    November 01, 2020 - Effectiveness Reviews Affiliation: Duke University Report Status: Final Screening for Hepatitis

27. Technical Specifications for Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-technical-specifications.pdf
    April 26, 2018 - Technical Specifications for Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock Section 2. Technical Specifications Sepsis Measure 5: Timely Fluid Bolus for Children with Severe Sepsis or Septic Shock 1 Description The proportion of hospitalized children with severe sepsis or septic shock w…

28. Agency for Healthcare Research and Quality: A Profile | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/cpi/about/profile/index.html
    July 01, 2022 - funding from the State of New Mexico, spreading to other States, and expanding from its initial focus on hepatitis

29. Search Evidence-Based Reports | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/research/findings/evidence-based-reports/search.html?page=5
    April 01, 2021 - Pacific Northwest EPC—Oregon Health & Science University Report Status: Final Screening for Hepatitis

30. Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
    August 01, 2014 - Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications Q-METRIC Sepsis Measure 4, Timely Administration of Antibiotics for Severe Sepsis and Septic Shock U18HS020516 Page 50 Submitted August 2014 Sepsis Measure 4: Timely Antibiotics for Children with Severe Sepsis or …

31. AHRQ Views Blog: Initiative Launched To Train a New Generation of Learning Health System Scientists | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/news/newsletters/e-newsletter/849.html
    February 01, 2023 - Literature Improving access to high-value, high-cost medicines: the use of subscription models to treat hepatitis

32. Section 2, Technical Specifications (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-tech-specs.pdf
    June 15, 2018 - Section 2, Technical Specifications 1 Sepsis Measure 6: Documentation of Heart Rate during Fluid Resuscitation in Children with Severe Sepsis or Septic Shock Description The proportion of hospitalized children with severe sepsis or septic shock who had documentation of heart rate at least every…

33. CHIPRA 213: Section 5, Table 4 (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
    January 01, 2012 - CHIPRA 213: Section 5, Table 4 Table 4: Evidence Supporting Hydroxyurea Treatment for Children with Sickle Cell Disease TYPE OF EVIDENCE KEY FINDINGS LEVEL OF EVIDENCE (USPSTF RANKING*) CITATIONS Randomized controlled trial The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH), a ra…

34. How did CHIPRA quality demonstration States employ learning collaboratives to improve children’s health care quality? | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/highlight13.html
    June 01, 2015 - For 2 year olds, this rate includes hepatitis A, hepatitis B, MMR, varicella, polio, DTP, pneumococcal

35. Maternity Care Performance Measurement Set (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/CHIPRA-BMI-Maternity-Care-Measures.pdf
    February 23, 2012 - for neural tube defects; screening for Gestational Diabetes; screening for Asymptomatic Bacteriuria; Hepatitis … B specific antigen screening at first visit (patients with documented immunity to Hepatitis B or active … Hepatitis B are excluded)  HIV screening at first visit (patients with a diagnosis of HIV are excluded … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis

36. How did CHIPRA quality demonstration States employ learning collaboratives to improve children's health quality? Evaluation Highlight #13 (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/highlight13.pdf
    September 08, 2015 - For 2 year olds, this rate includes hepatitis A, hepatitis B, MMR, varicella, polio, DTP, pneumococcal

37. Outpatient Medication Errors Prevalent Among Pediatric Leukemia, Lymphoma Patients | Agency for Healthcare Research and Quality
    www.monahrq.ahrq.gov/news/newsletters/e-newsletter/848.html
    January 01, 2023 - Skip to main content An official website of the Department of Health and Human Services Careers Contact Us Español FAQs Search all AHRQ sites Search small Search Menu …

38. HF Measures For Public Comment (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085maternity.pdf
    February 23, 2012 - for neural tube defects; screening for Gestational Diabetes; screening for Asymptomatic Bacteriuria; Hepatitis … B specific antigen screening at first visit (patients with documented immunity to Hepatitis B or active … Hepatitis B are excluded)  HIV screening at first visit (patients with a diagnosis of HIV are excluded … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis

39. HF Measures For Public Comment (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0082maternity.pdf
    February 23, 2012 - for neural tube defects; screening for Gestational Diabetes; screening for Asymptomatic Bacteriuria; Hepatitis … B specific antigen screening at first visit (patients with documented immunity to Hepatitis B or active … Hepatitis B are excluded)  HIV screening at first visit (patients with a diagnosis of HIV are excluded … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis

40. HF Measures For Public Comment (pdf file)
    www.monahrq.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085maternitycare.pdf
    February 23, 2012 - for neural tube defects; screening for Gestational Diabetes; screening for Asymptomatic Bacteriuria; Hepatitis … B specific antigen screening at first visit (patients with documented immunity to Hepatitis B or active … Hepatitis B are excluded)  HIV screening at first visit (patients with a diagnosis of HIV are excluded … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis … for neural tube defects; Screening for Gestational Diabetes; Screening for Asymptomatic Bacteriuria; Hepatitis